Presentation Transcript
INTRAEPIDERMAL IMMUNOBULLOUS DISEASES :INTRAEPIDERMAL IMMUNOBULLOUS DISEASES By: Dr. Deepak Kumar
IMMUNOBULLOUS DISEASES :IMMUNOBULLOUS DISEASES INTRAEPIDERMAL
PEMPHIGUS Group
SUBEPIDERMAL
BULLOUS PEMPHIGOID
MUCOUS MEMBRANE PEMPHIGOID
PEMPHGOID GESTATIONIS
LINEAR IgA DISEASE
BULLOUS SLE
DERMATITIS HERPETIFORMIS
EPIDERMOLYSIS BULLOSA ACQUISITA
INTRAEPIDERMAL IMMUNOBULLOUS DISEASES :INTRAEPIDERMAL IMMUNOBULLOUS DISEASES Autoantibodies against cell-cell adhesion molecule
Immune complexes deposited b/w keratinocytes
Cells separate from each other
Blisters within the Epidermis
Types of pemphigus :Types of pemphigus Pemphigus Vulgaris
Pemphigus Vegetans
Pemphigus Foliaceus
P. Herpetiformis
P. Erythemetosus
Induced Pemphigus
Intercellular IgA Dermatosis
Paraneoplastic Pemphigus
Intercellular adhesion :Intercellular adhesion Adherens Junction
Desmosomes
Cadherins
Desmogleins
Desmocollins
Submembranous Plaque
Plakophilin
Plakoglobin
Desmoplakin
Desmosomes :Desmosomes
Pemphigus Vulgaris :Pemphigus Vulgaris 70% of all pemphigus patients.
Both sexes
Middle age
More common in Jews and people of Mediterranean descent.
HLA-DRB1
pathogenesis :pathogenesis Pemphigus vulgaris antigen
Desmoglein 3(Dsg3)
Antibodies
IgG4
Clinical features :Clinical features Oral lesions
50–70% of patients
Clinical features :Clinical features Cutaneous lesions
Flaccid blisters
Erosions heal without scaring
diagnosis :diagnosis
histopathology :histopathology Acantholysis
Clefts and blisters
Row of tombstones
TZANCK PREPARATION :TZANCK PREPARATION ACANTHOLYTIC ,FREE FLOATING CELLS
ELECTRON MICROSCOPY :ELECTRON MICROSCOPY Widening of intercellular space
Cytokeratin tonofilaments retract around the nucleus
Desmosomal plaques disappear
Attachment of basal cells to BM is not affected
immunofluorescence :immunofluorescence
Pemphigus vegetans :Pemphigus vegetans Rare variant of pemphigus vulgaris
Disease starts -- earlier age
Oral mucosa involvement -- almost invariable
Lesions -- primarily flexural
Two subtypes
Neumann pemphigus vegetans
Hallopeau pemphigus vegetans
PEMPHIGUS VEGETANS :PEMPHIGUS VEGETANS NEUMANN TYPE
Vesicles and bullae rupture to form hypertrophic granulating erosions
Vegetating masses exuding serum and pus
HALLOPEAU TYPE
Pustules characterize early lesions progress to vegetating plaques
Clinical features :Clinical features
HISTOPATHOLOGY :HISTOPATHOLOGY The vegetating lesions are hyperkeratotic, papillomatous and acanthotic
Eosinophilic microabscesses – common in Hallopeau type
Dermis infiltrated lymphos, eosinophils & some neutros
Direct IMF: show IgG
Differential diagnosis of pemphigus vulgaris :Differential diagnosis of pemphigus vulgaris Oral lesions
Acute herpetic stomatitis
Erythema multiforme
Aphthous ulcers
Bullous lichen planus
Acute Herpetic Stomatitis :Acute Herpetic Stomatitis
Erythema Multiforme :Erythema Multiforme
Aphthous Ulcers :Aphthous Ulcers
ORAL LICHEN PLANUS :ORAL LICHEN PLANUS
Differential diagnosis of pemphigus vulgaris :Differential diagnosis of pemphigus vulgaris Cutaneous lesions
Bullous pemphigoid
Dermatitis herpetiformis
Hailey – Hailey disease
Darier’s disease
Grover’s disease
Bullous pemphigoid :Bullous pemphigoid
Dermatitis herpetiformis :Dermatitis herpetiformis
Darier's disease :Darier's disease
Grover's disease :Grover's disease
Hailey - Hailey disease :Hailey - Hailey disease
treatment :treatment Topical therapy
Systemic therapy
Topical therapy :Topical therapy Potent topical or intralesional steroids
Good oral hygiene
Potassium permanganate and topical antiseptics
Oral Antifungal
Systemic therapy :Systemic therapy Prednisolone
1.0–1.5 mg/kg/day in combination with topical.
High dose Prednisolone
120–240 mg/day for severe pemphigus
Azathioprine
2.5 mg/kg/day
Combination more effective
Oral and Intramuscular Gold
Tetracycline in combination
Dapsone
Systemic therapy :Systemic therapy Cyclophosphamide
1–3 mg/kg/day in combination
Ciclosporin 5mg/kg/day
Mycophenolate mofetil
2 g/day as steroid sparing
Plasmapheresis
reduces the titres of autoantibody by 15%
Methotrexate not effective
High-dose intravenous immunoglobulin
Extracorporeal Photophoresis with PUVA
Pemphigus Foliaceus :Pemphigus Foliaceus Blistering is high in the epidermis, granular layer or just beneath the stratum corneum.
10–20% of cases of pemphigus
Pemphigus Foliaceus antigen is desmoglein 1
Antibodies IgG
Clinical features :Clinical features Scattered scaly lesions involving the ‘seborrhoeic’ areas: scalp, face, chest and upper back
Crusted erosions surrounded by erythema
Oral lesions are uncommon
Clinical features :Clinical features
histopathology :histopathology Vacuoles form in the intercellular spaces in the upper levels of the epidermis
pemphigus herpetiformis :pemphigus herpetiformis Cluster of pruritic papules and vesicles on erythematous background
Biopsies show subcorneal pustules without acantholysis
Immunofluorescence--- intercellular staining
Pemphigus erythematosus (Senear -Usher syndrome) :Pemphigus erythematosus (Senear -Usher syndrome) Immunological features of both lupus erythematosus and pemphigus
ANA present
Erythematous scaly lesions over the nose and cheeks in a butterfly distribution
Lesions on the trunk similar to P. Foliaceus
pemphigus erythematosus :pemphigus erythematosus
Differential diagnosis of pemphigus Foliaceus :Differential diagnosis of pemphigus Foliaceus Seborrhoeic dermatitis
Impetigo
Seborrhoeic dermatitis :Seborrhoeic dermatitis
impetigo :impetigo
treatment :treatment Potent topical or intralesional steroids
Prednisolone 20–40 mg/day
Hydroxychloroquine 200 mg twice daily
Azathioprine or cyclophosphamide are adjuncts
Dapsone 100–300 mg/day
Drug of choice for P. Herpetiformis
I.V IG -- resistant cases
Mycophenolate mofetil
prognosis :prognosis P. Foliaceus is a benign but chronic ds
Responds well but remit
ENDEMIC P. FOLIACEUS (WILD FIRE, FOGO SELVAGEM) :ENDEMIC P. FOLIACEUS (WILD FIRE, FOGO SELVAGEM) Endemic to South America
Environmental factor – Insect bite
Black Fly – risk factor
Affects children & young adults
Flaccid bullae which rupture easily leaving erosions
Nikolsky's sign is +ve
ENDEMIC P. FOLIACEUS :ENDEMIC P. FOLIACEUS Head & neck involved 1st
Sun exposure causes burning sensation
Oral mucosa usually spared
Chronic ds is frequent with disseminated verrucous lesions
Growth retardation is common
TREATMENT :TREATMENT Similar to other P. foliaceus
Topical steroids for localized ds
Most pts respond to systemic steroids
Immunosuppressive agents, gold & antimalarials are recommended
PROGNOSIS :PROGNOSIS Before steroids 40-60% pts died
Now mortality reduced to 10%
Spontaneous remission have been reported
INDUCED PEMPHIGUS :INDUCED PEMPHIGUS Drugs – induce / exacerbate
P. foliaceus or P. erythematosus are common
Prognosis : spontaneous remission on drug withdrawal
40-50 % of Thiol gp drugs
15 % of Non thiol drugs
DRUGS :DRUGS
INTERCELLULAR IgA DERMATOSIS :INTERCELLULAR IgA DERMATOSIS Intercellular IgA deposition in epidermis
Affects adults
Flaccid vesicles / pustules
Sites
Axillae, groin, face, trunk, scalp
Treatment
Responds to Dapsone
Poorly to steroids
SUBCORNEAL PUSTULAR DERMATOSIS :SUBCORNEAL PUSTULAR DERMATOSIS Chronic, relapsing pustular eruptions
Involves mainly trunk, flexures
More common in females, 40-50 yrs
Subcorneal neutrophils
Negative IMF
Dapsone is the treatment of choice
PARANEOPLASTIC PAMPHIGUS :PARANEOPLASTIC PAMPHIGUS Pemphigus associated with underlying neoplasm
B-cell Lymphoproliferative disorders
Thymoma, Sarcomas & Carcinomas
Pts have severe mucosal erosions & polymorphous skin lesions – blisters, erosions
2/3rd cases – existing neoplasm
1/3rd cases – neoplasm detected after lesions
PARANEOPLASTIC PAMPHEGUS :PARANEOPLASTIC PAMPHEGUS BIOPSY: necrosis of keratinocytes with suprabasal clefting & acantholysis
DIMF– reveals Ig or complement at BM zone & also at keratinocytes
Antiplakin antibodies of IgG1 subclass
But not specific
TREATMENT :TREATMENT Refractory to all treatment
Steroids, AZT, Ciclosporin, Mycophenolate mofetil, plasmapheresis have been tried
DEATH
Sepsis
GI bleeding
Multiorgan failure
Respiratory failure